Journal of Internal Medicine

• 

  Año 2015, Vol. 277, Número 2

  • Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients

    M.D. Amaral

    • Resumen

    págs. 155-166

    

  • Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs

    J. Stingl, R. Viviani

    • Resumen

    págs. 167-177

    

  • Personalized medicine in rheumatoid arthritis: is the glass half full or half empty?

    T.W.J. Huizinga

    • Resumen

    págs. 178-187

    

  • An epidemiological perspective of personalized medicine: the Estonian experience

    L. Milani, L. Leitsalu, A. Metspalu

    • Resumen

    págs. 188-200

    

  • Pharmacogenomic biomarkers for personalized cancer treatment

    C. Rodriguez-Antona, Miquel Taron

    • Resumen

    págs. 201-217

    

  • Personalized medicine approaches in epilepsy

    L.E. Walker, N. Mirza, V.L.M. Yip, A.G. Marson, Munir Pirmohamed

    • Resumen

    págs. 218-234

    

  • Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?

    Azita Emami, E. Schaeffeler, A.T. Nies, K. Mörike, Matthias Schwab

    • Resumen

    págs. 235-247

    

  • Pharmacological reactivation of p53 as a strategy to treat cancer

    J. Zawacka-Pankau, G. Selivanova

    • Resumen

    págs. 248-259

    

  • Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain

    Y. Devaux, M. Mueller, P. Haaf, E. Goretti, R. Twerenbold

    • Resumen

    págs. 260-271